SUSMED,Inc. (TYO:4263)
Japan · Delayed Price · Currency is JPY 622.00
+4.00 (0.65%)
Jun 4, 2026, 11:30 AM JST
SUSMED,Inc. Balance Sheet
Financials in millions JPY. Fiscal year is July - June.
Millions JPY. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Cash & Equivalents | 3,958 | 4,398 | 4,846 | 5,048 | 4,904 | 1,626 |
Cash & Short-Term Investments | 3,958 | 4,398 | 4,846 | 5,048 | 4,904 | 1,626 |
Cash Growth | -12.86% | -9.25% | -4.00% | 2.94% | 201.60% | 344.26% |
Accounts Receivable | 7 | 15 | 10 | 10 | 9 | 5 |
Other Receivables | 6 | - | 9 | - | - | 11 |
Receivables | 13 | 15 | 19 | 10 | 9 | 16 |
Prepaid Expenses | 60 | 47 | 30 | 25 | 21 | 26 |
Other Current Assets | 5 | 2 | 3 | 2 | 1 | 6 |
Total Current Assets | 4,036 | 4,462 | 4,898 | 5,085 | 4,935 | 1,674 |
Long-Term Investments | 100 | 24 | 25 | 8 | 8 | - |
Other Intangible Assets | 85 | 16 | 8 | 7 | - | - |
Other Long-Term Assets | 2 | - | 1 | 1 | - | - |
Total Assets | 4,223 | 4,502 | 4,932 | 5,101 | 4,943 | 1,674 |
Accounts Payable | - | 1 | - | - | - | - |
Accrued Expenses | 5 | 1 | 1 | 1 | 1 | - |
Current Income Taxes Payable | 59 | 71 | 67 | 82 | 70 | 81 |
Current Unearned Revenue | - | - | - | - | - | 6 |
Other Current Liabilities | 50 | 52 | 253 | 141 | 16 | 9 |
Total Current Liabilities | 114 | 125 | 321 | 224 | 87 | 96 |
Other Long-Term Liabilities | 1 | 7 | 7 | 7 | 6 | 1 |
Total Liabilities | 115 | 132 | 328 | 231 | 93 | 97 |
Common Stock | 117 | 99 | 80 | 40 | 1,853 | 100 |
Additional Paid-In Capital | 5,459 | 5,441 | 5,423 | 5,383 | 3,509 | 1,756 |
Retained Earnings | -1,550 | -1,218 | -920 | -562 | -511 | -278 |
Comprehensive Income & Other | 82 | 48 | 21 | 9 | -1 | -1 |
Shareholders' Equity | 4,108 | 4,370 | 4,604 | 4,870 | 4,850 | 1,577 |
Total Liabilities & Equity | 4,223 | 4,502 | 4,932 | 5,101 | 4,943 | 1,674 |
Net Cash (Debt) | 3,958 | 4,398 | 4,846 | 5,048 | 4,904 | 1,626 |
Net Cash Growth | -12.86% | -9.25% | -4.00% | 2.94% | 201.60% | 344.26% |
Net Cash Per Share | 235.09 | 261.90 | 290.30 | 307.76 | 333.99 | 127.09 |
Filing Date Shares Outstanding | 16.86 | 16.81 | 16.74 | 16.55 | 16.11 | 12.79 |
Total Common Shares Outstanding | 16.86 | 16.81 | 16.74 | 16.55 | 16.11 | 12.79 |
Working Capital | 3,922 | 4,337 | 4,577 | 4,861 | 4,848 | 1,578 |
Book Value Per Share | 243.63 | 259.94 | 275.06 | 294.25 | 301.11 | 123.26 |
Tangible Book Value | 4,023 | 4,354 | 4,596 | 4,863 | 4,850 | 1,577 |
Tangible Book Value Per Share | 238.59 | 258.98 | 274.58 | 293.83 | 301.11 | 123.26 |